News from the Health System Node: INEBRIA presentation, Prenatal cannabis use, Upcoming webinar

Stacy Sterling, DrPH, MSW, MPH, and Derek Satre PhD, Health System Node faculty, hosted the International Network on Brief Intervention for Alcohol or Other Drugs (INEBRIA) conference in San Francisco, CA on September 24-26, 2025.  INEBRIA is dedicated to evaluating the effectiveness of brief interventions in different settings with different types of patients. A great turn out, with more than 130 researchers from around the world in attendance.

Research by Kelly Young-Wolff, PhD, MPH, Health System Node faculty, and Research Scientist at the Kaiser Permanente Northern California Division of Research, was highlighted in the new ACOG guidelines on prenatal cannabis use.

Upcoming online seminar

The new Health Systems Node Seminar Series presents Lessons Learned About Treating Co-occurring Conditions Among Adults Receiving Substance Use Disorder Treatment with Dr. Mark Ilgen, PhD. Join us for online seminar on November 6, 2025 @ 10 am PT. No registration required. Contact Morgan Ford for more information: morgan.ford@kp.org.

Website/link to join:
Join the Microsoft Teams Meeting here
Meeting ID: 250 658 877 216 6
Passcode: B8jq2m9A

Description: Co-occurring mental health and physical problems are common among patients receiving treatment for substance use disorders. When present, these issues typically predict poorer functional and substance-related outcomes following treatment. This suggests that addressing co-occurring problems during an episode of substance use disorder treatment could significantly improve a wide range of outcomes. However, prior studies have yielded somewhat inconsistent results regarding the additional and/or synergistic benefits of treating co-occurring mental health and physical problems beyond the standard effects of substance use disorder treatment alone. In this virtual seminar, Dr. Mark Ilgen will briefly review the results of three large-scale randomized trials that targeted distinct issues—chronic pain, suicide risk, and insomnia—commonly faced by patients in substance use disorder treatment. He will then discuss common themes across these studies, as well as potential lessons learned for clinicians and researchers interested in treating complex substance use disorder patients in real-world settings.